Last week, INNOPROM 2017, an international industrial exhibition, came to an end at the Expocentre.
The «Medsintez» plant took part in the exhibition of achievements of the domestic pharmaceutical and medical industry held as part of the state program named 'Pharmaceutical and Medical Industry Development for 2013-2020' in Moscow.
Insulin developers from Sverdlovsk will receive 183 million roubles to expand their production. Almost 200 million roubles will be invested in the insulin production in the Urals. The money will be allocated by the Industry Development Fund. The loan will be directed to the expansion of the first biopharmaceutical import-substituting production of genetically engineered insulin.
Triazavirin has been recommended for use by the Ministry of Health of the Russian Federation.
+7 (34370) 2-50-61
+7 (34370) 2-54-95
Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130